Given the documented involvement of the OBSCN gene in the development of cardiomyopathies (19), we next interrogated whether the expression levels of obscurin-B containing kin1 and phospho-Ser-788 N-cadherin are altered in human end-stage heart failure DCM samples (Table 1). The gene discussed is OBSCN; the disease is cardiomyopathy.